The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A comparison of three clinical factors as predictive markers for response to immunotherapy in non-small cell lung cancer.
 
Isabel Ruth Preeshagul
No Relationships to Disclose
 
Kevin M. Sullivan
No Relationships to Disclose
 
Doru Paul
No Relationships to Disclose
 
Robert G. Maki
Honoraria - Lilly; Springer; Wiley
Consulting or Advisory Role - AADi; American Board of Internal Medicine (ABIM); Arcus Ventures; Bayer; Deciphera; Eisai; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Daiichi Sankyo (Inst); Immune Design (Inst); Immunocore (Inst); Lilly (Inst); Presage Biosciences (Inst); Regeneron (Inst); TRACON Pharma (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - TRACON Pharma
 
Nagashree Seetharamu
No Relationships to Disclose